Stigma perception and determinants among patients with type 2 diabetes mellitus in Iraq

Author:

Taher Taqi M. J.,Ahmed Hussein A.,Abutiheen Ali A.,Alfadhul Shaymaa A.,Ghazi Hasanain F.ORCID

Abstract

Abstract Background and purpose Diabetes mellitus (DM) is a leading cause of death worldwide. Stigma is a sign of social disgrace occurring within public relations, and it is linked with many health conditions including diabetes. Stigma could worsen the disease course, reduce treatment adherence, and affect the quality of life of diabetic patients. The objective of this study was to assess the magnitude of diabetic stigma among patients with type 2 DM. Methods In this analytic cross-sectional study, data collection was performed from June 1, 2022, until November 1, 2022, et al.-Najaf City, Iraq. A consecutive sample of 429 patients with type 2 DM was interviewed using the Arabic version of the type 2 Diabetes Stigma Assessment Scale (DSAS-2), which is a validated tool. The total diabetic stigma score, treated differently score, self-stigma score, and blame and judgment score were estimated. Results The mean age of the sample was 56.6 years, and males represented 61.8% of them. The total diabetic stigma score mean was 51.72. The question regarding people's judgment of food choices showed the highest rate (53%) among patients. Problematic stigma appeared in 24.71% of DM patients. Lower educational level, being divorced or widow, age above 50 years, being unemployed or housewife, and lower income showed significantly higher diabetic stigma scores. Conclusion One-quarter of type 2 DM patients showed problematic stigma. The mean diabetic stigma score was significantly higher among patients with lower education, divorced or widow status, older age, unemployment or housewife category, and low-income status.

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Reference41 articles.

1. World Health Organization. Fact sheets, Diabetes. Last updated on November 10, 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/diabetes. [Accessed 11 Mar 2022].

2. Magliano DJ, Islam RM, Barr EL, Gregg EW, Pavkov ME, Harding JL, et al. Trends in incidence of total or type 2 diabetes: a systematic review. BMJ. 2019;366. https://doi.org/10.1136/bmj.l5003.

3. International Diabetes Federation (IDF). Facts and figures. Available from: https://idf.org/aboutdiabetes/what-is-diabetes/facts-figures.html. [Accessed 23 May 2022].

4. International Diabetes Federation (IDF). The IDF Diabetes Atlas 10th edition 2021. Diabetes in Middle-East & North Africa. Available at: https://diabetesatlas.org/. [Accessed 23 May 2022].

5. Farmanfarma KK, Ansari-Moghaddam A, Zareban I, Adineh HA. Prevalence of type 2 diabetes in Middle–East: Systematic review& meta-analysis. Prim Care Diabetes. 2020;14(4):297–304. https://doi.org/10.1016/j.pcd.2020.01.003.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3